青岛海尔生物医疗股份有限公司 关于股东增持股份达到5%的权益 变动提示性公告

Core Viewpoint - The announcement details that Qingdao Jiushi Investment Management Co., Ltd. has increased its stake in Haier Biomedical to 5% without triggering a mandatory takeover bid [2][3]. Group 1: Shareholding Changes - Jiushi Youxuan No. 1 Private Securities Investment Fund acquired 15,897,909 shares of Haier Biomedical from August 14, 2024, to October 14, 2025, representing 5% of the total share capital [4][10]. - The increase in shareholding does not change the company's controlling shareholder or actual controller [3][5]. Group 2: Investment Rationale - The investment is based on confidence in the future development of the life sciences industry and recognition of Haier Biomedical's governance, industry position, business capabilities, operational results, and risk management [10]. - Jiushi Youxuan No. 1 has no current plans to increase or decrease its stake in the next 12 months [11]. Group 3: Compliance and Reporting - The report complies with relevant laws and regulations, including the Securities Law and the Management Measures for the Acquisition of Listed Companies [7][12]. - The report confirms that the information disclosed is accurate and complete, with no misleading statements or omissions [12].